NCT03641924

Brief Summary

Posttraumatic stress disorder (PTSD) is prevalent among combat Veterans and is a substantial public health burden. Several psychotherapies, including cognitive processing therapy (CPT) and prolonged exposure therapy, have been recommended as efficacious for the treatment of PTSD and are being disseminated nationally in the VA Healthcare System. Yet many individuals show limited benefit from such treatments. Accumulating evidence indicates that episodic memory deficits may be one factor limiting psychotherapy treatment efficacy in PTSD. The proposed study will determine whether verbal memory is a specific predictor of CPT outcomes in PTSD, including both symptom reductions and functional outcomes. The study will also determine the pathways by which memory functioning affects treatment outcomes by examining relationships between memory functioning, treatment engagement, recall of treatment content, and illness course. More specifically, analyses will examine whether memory for treatment content affects the relationship between memory functioning and treatment outcomes.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
110

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started May 2019

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 20, 2018

Completed
2 days until next milestone

First Posted

Study publicly available on registry

August 22, 2018

Completed
9 months until next milestone

Study Start

First participant enrolled

May 20, 2019

Completed
4.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 29, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 29, 2023

Completed
1.6 years until next milestone

Results Posted

Study results publicly available

May 9, 2025

Completed
Last Updated

May 9, 2025

Status Verified

May 1, 2025

Enrollment Period

4.4 years

First QC Date

August 20, 2018

Results QC Date

December 26, 2024

Last Update Submit

May 7, 2025

Conditions

Keywords

Posttraumatic Stress DisorderPsychotherapyNeuropsychology

Outcome Measures

Primary Outcomes (2)

  • Change in PTSD Checklist (PCL-5)

    PTSD Symptoms. The range of the scale is from 0 (no symptoms) to 80 (maximal symptoms). Higher scores corresponds to more symptoms.

    Change from baseline to 12 weeks

  • Social Adjustment Scale-Self Report (SAS-SR)

    Functional Status. Scored 1-5, with higher scores indicating worse functioning.

    Change from baseline to 12 weeks

Secondary Outcomes (1)

  • Veterans RAND 12 Item Health Survey Mental Component Summary (VR-12 MCS)

    Change from baseline to 12 weeks

Study Arms (1)

PTSD

Veterans diagnosed with Diagnostic and Statistical Manual (DSM-V) PTSD

Behavioral: Cognitive Processing Therapy

Interventions

Cognitive Processing Therapy is an evidence-based psychotherapy for PTSD.

PTSD

Eligibility Criteria

Age18 Years - 70 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Veterans

You may qualify if:

  • DSM-5 criteria for PTSD via the Clinician Administered PTSD Scale (CAPS-5)
  • Willing to initiate CPT

You may not qualify if:

  • Substance use disorder (moderate or above) not in remission for \>1 mo
  • Severe psychiatric illness (e.g., psychosis)
  • Significant current suicidal or homicidal intent, including a specific plan
  • Dementia, neurological disorder, or severe traumatic brain injury (TBI; i.e., loss of consciousness \> 24h)
  • Inability to speak or read English

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Corporal Michael J. Crescenz VA Medical Center, Philadelphia, PA

Philadelphia, Pennsylvania, 19104-4551, United States

Location

MeSH Terms

Conditions

Stress Disorders, Post-Traumatic

Condition Hierarchy (Ancestors)

Stress Disorders, TraumaticTrauma and Stressor Related DisordersMental Disorders

Results Point of Contact

Title
Dr. James Cobb Scott
Organization
Corporal Michael J. Crescenz VAMC

Study Officials

  • James C. Scott, PhD

    Corporal Michael J. Crescenz VA Medical Center, Philadelphia, PA

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
PROSPECTIVE
Sponsor Type
FED
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 20, 2018

First Posted

August 22, 2018

Study Start

May 20, 2019

Primary Completion

September 29, 2023

Study Completion

September 29, 2023

Last Updated

May 9, 2025

Results First Posted

May 9, 2025

Record last verified: 2025-05

Data Sharing

IPD Sharing
Will share

Final datasets will be shared upon written request. The PI and his team will create de-identified, study-specific dataset, replacing identifying information with study-specific codes. Investigators requesting access to a dataset will be asked to sign a Letter of Agreement or Data Use Agreement that will need to be approved by the local VA Information Security Officers and Privacy Officer. The investigators will follow specific VA Office of Research \& Development Guidance.

Shared Documents
STUDY PROTOCOL, ANALYTIC CODE
Time Frame
Datasets meeting VA standards for disclosure to the public will be made available within one year of publication of primary results.

Locations